Natera, Inc. (NTRA) CEO Steve Chapman on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/08/21
Natera Q2 Sales Tops Street Estimates On Higher Volumes, Raises FY21 Sales OutlookBenzinga • 08/06/21
Natera Announces Use of Signatera® as a Companion Diagnostic in GSK's Phase III ZEST Trial for Niraparib in Early-Stage Breast CancerPRNewsWire • 08/04/21
New Study Validates the Signatera® MRD Test and Demonstrates its Clinical Utility in Early-Stage Esophageal CancerPRNewsWire • 07/28/21
New Publication Shows 96% Overall Survival Among Metastatic Colorectal Cancer Patients Who Test MRD-Negative with Signatera® After SurgeryPRNewsWire • 07/22/21
New Results From the Landmark Prospective CIRCULATE Trial Expand Clinical Utility of the Signatera® MRD Test in Colorectal CancerPRNewsWire • 07/02/21
Natera: Leading cfDNA Diagnostics Company Offers Strong Growth And Fair Trading ValueSeeking Alpha • 07/01/21
Natera and BGI Genomics Announce Commercial Launch of the BGI/Natera Signatera Assay in ChinaPRNewsWire • 06/24/21
Natera Awarded Advanced Diagnostic Laboratory Test (ADLT) Status for its Signatera® MRD Test From CMSPRNewsWire • 06/18/21
Nature Journal Publishes Prospective, Randomized Study Validating Signatera® for Prediction of Immunotherapy BenefitPRNewsWire • 06/16/21
Foundation Medicine Launches FoundationOne®Tracker ctDNA Monitoring Assay for Research Use in Partnership with NateraPRNewsWire • 06/08/21
Naturally Splendid trims loss in 1Q results, turns focus to higher-margin products like NATERA Plant Based FoodsProactive Investors • 06/01/21
Natera Responds to Meritless Lawsuit and Files False Advertising Claim Against Guardant for Misleading OncologistsPRNewsWire • 05/28/21
New Signatera™ Data in Multiple Myeloma, Colorectal Cancer and Ovarian Cancer Highlights Clinical Utility of MRD in Real-World SettingsPRNewsWire • 05/26/21
Natera to Present Clinical Data from Largest Prospective MRD-Guided Trial in Colorectal Cancer at the 2021 ASCO Annual MeetingPRNewsWire • 05/20/21
Natera's (NTRA) CEO Steve Chapman on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/09/21
Natera to Present New Colorectal Cancer and Multiple Myeloma Data at the 2021 Annual ASCO MeetingPRNewsWire • 05/03/21